StockData
Regen BioPharma Inc logo

Regen BioPharma Inc (RGBP) stock

RGBPOTCPharmaceutical PreparationsFiscal year ends September 30Also trades as RGBPP
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 17, 2026Score 2/30
$0.00+0.00 (+50.00%)

Close on Oct 19, 2026Market cap $92.33KP/E –Yield –

Regen BioPharma profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Regen BioPharma's profit margin for the twelve months ending Jun 30, 2026 was -501.4%. For fiscal 2025 it was -538.8%, against -282.5% the year before. The highest annual figure on record is 3104.0% in fiscal 2020.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Sep 30, 2025-538.8%−256.3
FY2024Sep 30, 2024-282.5%−771.4
FY2023Sep 30, 2023488.9%−1457.9
FY2022Sep 30, 20221946.8%+13002.2
FY2021Sep 30, 2021-11055.4%−14159.4
FY2020Sep 30, 20203104.0%+5488.7
FY2019Sep 30, 2019-2384.7%+2330.5
FY2018Sep 30, 2018-4715.2%+593.0
FY2017Sep 30, 2017-5308.2%+2442.4
FY2016Sep 30, 2016-7750.6%−1919.8
FY2015Sep 30, 2015-5830.8%–

Quarterly profit margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q3 FY2026CQ2 2026Jun 30, 2026-1079.8%−796.6
Q2 FY2026CQ1 2026Mar 31, 20261679.4%+1712.1
Q1 FY2026CQ4 2025Dec 31, 2025-1638.6%−766.1
Q4 FY2025CQ3 2025Sep 30, 2025-964.3%−508.2
Q3 FY2025CQ2 2025Jun 30, 2025-283.2%−62.9
Q2 FY2025CQ1 2025Mar 31, 2025-32.8%+174.6
Q1 FY2025CQ4 2024Dec 31, 2024-872.6%−627.2
Q4 FY2024CQ3 2024Sep 30, 2024-456.1%+91.4
Q3 FY2024CQ2 2024Jun 30, 2024-220.3%−52.3
Q2 FY2024CQ1 2024Mar 31, 2024-207.3%−33.6
Q1 FY2024CQ4 2023Dec 31, 2023-245.4%−5415.2
Q4 FY2023CQ3 2023Sep 30, 2023-547.5%−300.9
Q3 FY2023CQ2 2023Jun 30, 2023-168.0%−214146.5
Q2 FY2023CQ1 2023Mar 31, 2023-173.8%+216603.1
Q1 FY2023CQ4 2022Dec 31, 20225169.8%−3189.8
Q4 FY2022CQ3 2022Sep 30, 2022-246.6%+4082.1
Q3 FY2022CQ2 2022Jun 30, 2022213978.5%+239620.9
Q2 FY2022CQ1 2022Mar 31, 2022-216776.8%−218389.2
Q1 FY2022CQ4 2021Dec 31, 20218359.6%+2283.5
Q4 FY2021CQ3 2021Sep 30, 2021-4328.7%−8667.1
Q3 FY2021CQ2 2021Jun 30, 2021-25642.4%−37332.2
Q2 FY2021CQ1 2021Mar 31, 20211612.3%+16478.9
Q1 FY2021CQ4 2020Dec 31, 20206076.1%−5164.6
Q4 FY2020CQ3 2020Sep 30, 20204338.4%−2406.3
Q3 FY2020CQ2 2020Jun 30, 202011689.9%+27752.2
Q2 FY2020CQ1 2020Mar 31, 2020-14866.5%−13651.7
Q1 FY2020CQ4 2019Dec 31, 201911240.7%+10347.2
Q4 FY2019CQ3 2019Sep 30, 20196744.7%+6852.3
Q3 FY2019CQ2 2019Jun 30, 2019-16062.3%−13677.4
Q2 FY2019CQ1 2019Mar 31, 2019-1214.9%+1230.8
Q1 FY2019CQ4 2018Dec 31, 2018893.6%–
Q3 FY2018CQ2 2018Jun 30, 2018-107.6%–
Q3 FY2017CQ2 2017Jun 30, 2017-2384.9%–
Q4 FY2016CQ3 2016Sep 30, 2016-2445.7%–

More Regen BioPharma figures

See a number that looks wrong?